Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amplitude Inc (AMPL) vs Baxter International Inc (BAX) Price & Performance

Amplitude Inc
Baxter International Inc

Price performance

Price movement over the last 24 hours

Key statistics

Amplitude Inc vs Baxter International Inc — how do they compare? Amplitude Inc trades at $9.21 (market cap $1.22B), while Baxter International Inc trades at $22.08 (market cap $11.68B). The key difference: Baxter International Inc is far larger — about 9.6× Amplitude Inc's market cap, and Baxter International Inc pays a 0.88% dividend while Amplitude Inc pays none. Which is the better fit depends on your goals.

AMPLBAX
Market Cap
$1.22B$11.68B
Sector
TechnologyHealth
52-Week High
$13.04$29.22
52-Week Low
$5.61$15.80
Enterprise Value
$1.05B$19.35B
Dividend Yield
0.88%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amplitude Inc

AMPL trades at $9.18, down 2.13% over the past day, with a bullish technical signal from moving averages but bearish oscillators. Revenue growth is strong, reaching $343.21M in 2025, yet the company remains unprofitable with a net income margin of -25.11%. Analyst consensus is bullish with a $9.25 price target, though recent news includes multiple law firm fraud investigations and a Bank of America downgrade citing profitability concerns.

The outlook hinges on AMPL's ability to translate robust revenue growth into profitability amid competitive pressures. Investment opportunity lies in potential margin expansion and market share gains, but risks include ongoing legal scrutiny, execution challenges, and persistent negative cash flows. The stock's near-term direction will likely be driven by upcoming earnings results and clarity on the fraud allegations.

Baxter International Inc

Baxter International (BAX) trades at $22.62, up 0.71% on the day, near the consensus price target of $22.67. The stock shows a bullish technical trend with recent earnings beats in Q1 2026, though profitability remains challenged with negative net income margins. Recent news highlights sustainability initiatives and upcoming Q2 2026 earnings, with analyst sentiment mixed but leaning hold.

Outlook hinges on operational turnaround amid margin pressures; upside exists if cost controls and innovation boost profits, but high debt and inconsistent cash flow pose risks. The stock offers speculative value for patient investors betting on recovery, but near-term volatility is likely until earnings stabilize.

Returns comparison

Trailing returns across standard periods

About Amplitude Inc

Amplitude Inc is pioneering a new category of software called digital optimization. The company's digital optimization system serves as the command center for businesses to connect digital products to business outcomes.

Read more on AMPL

About Baxter International Inc

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.

Read more on BAX